Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD): In Thursday's trading session, Ironwood Pharmaceuticals, Inc (NASDAQ:IRWD) dropped 3.12%. Its opening price of $15.01 was also the intraday high, which eventually headed down to close at $14.60 per ...

Ironwood Pharmaceuticals (NASDAQ: IRWD) is committed to the art and science of making medicines, from discovery through commercialization.

Ironwood Pharmaceuticals Inc.'s (IRWD) first-quarter loss widened more than Wall Street expected as the drug maker posted a sharp rise in operating expenses.

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)decreased 6.26% and closed at $16.77 on a traded volume of 2.98 million shares.

New York, NY -- (SBWIRE) -- 04/24/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), Cell Therapeutics, Inc. (NASDAQ:CTIC), and Exact Sciences Corporation ...

Wilmington, DE -- (SBWIRE) -- 04/23/2013 -- Equity Profile Report expands its NASDAQ Decliners Weekly Watch List adding IDEXX Laboratories, Inc. (NASDAQ:IDXX), Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD), and Achillion Pharmaceuticals, Inc.

New York, NY -- (SBWIRE) -- 05/07/2013 -- Growing Stock Report expands its NASDAQ Decliners Weekly Watch List adding AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Exact Sciences Corporation (NASDAQ:EXAS), and Ironwood Pharmaceuticals, Inc.

Citrix Systems, Inc.(NASDAQ:CTXS)went down 6.98% and closed at $62.94 on a traded volume of 9.07 million shares.The Company released first quarter results. Citrix reported profit of $59.7 million or 32 cents per share from $68.3 million or 36 cents a ...

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) moved down 4.53% to $17.05 on a traded volume of 1.23 million shares. The Company reported unaudited first quarter EPS of ($0.87), worse than the analyst estimate of ($0.64).

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) slipped 5.87% to $16.85 on a traded volume of 80k shares. The Company reported unaudited first quarter EPS of ($0.87), worse than the analyst estimate of ($0.64).